These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 343146)

  • 21. Piracetam in chronic brain failure.
    Lloyd-Evans S; Brocklehurst JC; Palmer MK
    Curr Med Res Opin; 1979; 6(5):351-7. PubMed ID: 540525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of piracetam on extrapyramidal side effects induced by neuroleptic drugs.
    Kabes J; Sikora J; Pisvejc J; Hanzlicek L; Skondia V
    Int Pharmacopsychiatry; 1982; 17(3):185-92. PubMed ID: 6128331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A controlled trial of piracetam in intellectually impaired patients with Parkinson's disease.
    Sano M; Stern Y; Marder K; Mayeux R
    Mov Disord; 1990; 5(3):230-4. PubMed ID: 2388639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Various therapeutic effects of piracetam (1st part)].
    Houillon P; Kitenge A; Jouannigot R; Lullien L; Cadic F
    Ann Med Psychol (Paris); 1979 Sep; 137(6-7):605-10. PubMed ID: 507608
    [No Abstract]   [Full Text] [Related]  

  • 25. Retrospective estimate of the nursing cost of autonomy impairment and cost benefit in clinical trials: feasibility and application of piracetam in demented elderly patients.
    Vlietinck R; Van Loon H; Van de Broele H; Tormans G
    Adv Ther; 1993; 10(5):226-44. PubMed ID: 10172000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Piracetam in premature biological aging. Double-blind study after preselection by drugs].
    Dorn M
    Fortschr Med; 1978 Aug; 96(30):1525-30. PubMed ID: 669550
    [No Abstract]   [Full Text] [Related]  

  • 27. [Piracetam--a drug for decreasing potency?].
    Hofmann N
    Med Welt; 1978 Jun; 29(26):1096-9. PubMed ID: 672574
    [No Abstract]   [Full Text] [Related]  

  • 28. Piracetam in alcoholic psychoses: a double-blind, crossover, placebo controlled study.
    Skondia V; Kabes J
    J Int Med Res; 1985; 13(3):185-7. PubMed ID: 3891457
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of therapeutic response to long-term treatment with lecithin versus piracetam plus lecithin in patients with Alzheimer's disease.
    Smith RC; Vroulis G; Johnson R; Morgan R
    Psychopharmacol Bull; 1984; 20(3):542-5. PubMed ID: 6433396
    [No Abstract]   [Full Text] [Related]  

  • 30. [Use of piracetam (nootropil) in the rehabilitative treatment of the middle-aged and elderly who have had a stroke].
    Man'kovskiĭ NB; Kostiuchenko VG; Tereshchenko LA; Tordiia GD
    Vrach Delo; 1980 Sep; (9):73-7. PubMed ID: 7423958
    [No Abstract]   [Full Text] [Related]  

  • 31. [Modification of the decrease in efficiency in the middle period of life. Experiences with piracetam (Nootropil) in professional practice].
    Radmayr E
    Wien Med Wochenschr; 1976 Sep; 126(3):527-9. PubMed ID: 793194
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of piracetam in children with learning disorders.
    Simeon J; Waters B; Resnick M
    Psychopharmacol Bull; 1980 Jul; 16(3):65-6. PubMed ID: 7403408
    [No Abstract]   [Full Text] [Related]  

  • 33. Piracetam in the management of spasticity in cerebral palsy.
    Maritz NG; Müller FO; Pompe van Meerdervoort HF
    S Afr Med J; 1978 Jun; 53(22):889-91. PubMed ID: 356288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical studies with piracetam].
    Eckmann F
    MMW Munch Med Wochenschr; 1976 Jul; 118(29-30):957-8. PubMed ID: 820987
    [No Abstract]   [Full Text] [Related]  

  • 35. [Use of piracetam in the treatment of cranial injuries. Observations on 903 cases].
    Cicerchia G; Santucci R; Palmieri M
    Clin Ter; 1985 Sep; 114(6):481-7. PubMed ID: 3905223
    [No Abstract]   [Full Text] [Related]  

  • 36. Piracetam plus lecithin trials in senile dementia of the Alzheimer type.
    Samorajski T; Vroulis GA; Smith RC
    Ann N Y Acad Sci; 1985; 444():478-81. PubMed ID: 3893273
    [No Abstract]   [Full Text] [Related]  

  • 37. [Therapeutic effects of Nootropyl].
    Houillon P; Kitenge A; Jouannigot R; Lullien L
    Ann Med Psychol (Paris); 1980; 138(7):869-76. PubMed ID: 7458110
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of alcohol organic mental disorder with piracetam.
    Barnas C; Miller C; Gunther V; Fleischhacker WW
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(6):729-37. PubMed ID: 3326044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pilot study of 2-pyrrolidon-acetamid (generic name: piracetam) (author's transl)].
    Tacke B; Freistein H; Kempf H; Windheuser A
    Pharmakopsychiatr Neuropsychopharmakol; 1975 Mar; 8(2):82-9. PubMed ID: 788004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the efficacy of piracetam in treating information processing, reading and writing disorders in dyslexic children.
    Tallal P; Chase C; Russell G; Schmitt RL
    Int J Psychophysiol; 1986 May; 4(1):41-52. PubMed ID: 3522509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.